ACELYRIN
Biopharma company focused on providing patients life-changing new treatment options. Learn more
Launch date
Employees
Market cap
€426m
Enterprise valuation
(€150m) (Public information from Sep 2024)
Share price
$5.3 SLRN
Los Angeles California (HQ)
Authorizing premium user...